Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exome | 75 | 2023 | 1263 | 4.010 |
Why?
|
Sequence Analysis, DNA | 94 | 2021 | 2477 | 3.400 |
Why?
|
Genetic Variation | 60 | 2021 | 2035 | 2.680 |
Why?
|
Genome | 35 | 2022 | 678 | 2.190 |
Why?
|
High-Throughput Nucleotide Sequencing | 44 | 2024 | 2323 | 2.120 |
Why?
|
Mutation | 98 | 2024 | 15589 | 2.050 |
Why?
|
Genomics | 55 | 2023 | 2800 | 1.940 |
Why?
|
Genome, Human | 38 | 2024 | 1845 | 1.900 |
Why?
|
Evolution, Molecular | 35 | 2020 | 846 | 1.800 |
Why?
|
Polymorphism, Single Nucleotide | 71 | 2022 | 4315 | 1.730 |
Why?
|
DNA Copy Number Variations | 29 | 2024 | 1528 | 1.680 |
Why?
|
Genetic Diseases, Inborn | 16 | 2019 | 450 | 1.610 |
Why?
|
Genetic Predisposition to Disease | 49 | 2023 | 5403 | 1.590 |
Why?
|
Pedigree | 55 | 2023 | 1880 | 1.500 |
Why?
|
Whole Genome Sequencing | 17 | 2023 | 351 | 1.370 |
Why?
|
Genome, Insect | 11 | 2020 | 102 | 1.320 |
Why?
|
Alleles | 32 | 2021 | 2390 | 1.260 |
Why?
|
Phenotype | 50 | 2024 | 6338 | 1.230 |
Why?
|
Genetic Association Studies | 28 | 2021 | 1062 | 1.180 |
Why?
|
Intellectual Disability | 14 | 2023 | 1040 | 1.130 |
Why?
|
Mutation, Missense | 20 | 2023 | 1193 | 1.060 |
Why?
|
Exons | 24 | 2020 | 1347 | 1.010 |
Why?
|
Genetic Testing | 17 | 2024 | 1653 | 0.970 |
Why?
|
Phylogeny | 26 | 2020 | 842 | 0.930 |
Why?
|
Clinical Laboratory Services | 1 | 2024 | 41 | 0.910 |
Why?
|
Genome-Wide Association Study | 26 | 2021 | 2086 | 0.890 |
Why?
|
Craniofacial Abnormalities | 7 | 2022 | 247 | 0.850 |
Why?
|
Humans | 307 | 2024 | 270194 | 0.850 |
Why?
|
Urogenital Abnormalities | 6 | 2023 | 177 | 0.840 |
Why?
|
Homozygote | 17 | 2024 | 737 | 0.790 |
Why?
|
Muscle Hypotonia | 7 | 2019 | 183 | 0.790 |
Why?
|
Membrane Proteins | 19 | 2023 | 2887 | 0.780 |
Why?
|
Abnormalities, Multiple | 11 | 2022 | 1014 | 0.760 |
Why?
|
Limb Deformities, Congenital | 5 | 2022 | 115 | 0.740 |
Why?
|
Dwarfism | 5 | 2022 | 107 | 0.730 |
Why?
|
Male | 169 | 2024 | 127386 | 0.700 |
Why?
|
Frameshift Mutation | 10 | 2023 | 230 | 0.690 |
Why?
|
Germ-Line Mutation | 9 | 2022 | 1059 | 0.680 |
Why?
|
Genome, Bacterial | 10 | 2012 | 202 | 0.670 |
Why?
|
INDEL Mutation | 9 | 2022 | 114 | 0.670 |
Why?
|
Female | 173 | 2024 | 147100 | 0.670 |
Why?
|
Open Reading Frames | 13 | 2021 | 245 | 0.660 |
Why?
|
Molecular Sequence Annotation | 12 | 2021 | 196 | 0.640 |
Why?
|
Macaca mulatta | 8 | 2020 | 769 | 0.640 |
Why?
|
Gene Frequency | 19 | 2021 | 1124 | 0.640 |
Why?
|
Molecular Sequence Data | 38 | 2016 | 6105 | 0.630 |
Why?
|
Genetic Loci | 8 | 2021 | 462 | 0.620 |
Why?
|
Software | 13 | 2024 | 1326 | 0.620 |
Why?
|
Biological Evolution | 7 | 2020 | 269 | 0.590 |
Why?
|
Animals | 104 | 2024 | 60992 | 0.570 |
Why?
|
Pharmacogenetics | 4 | 2022 | 264 | 0.560 |
Why?
|
Databases, Genetic | 15 | 2021 | 744 | 0.550 |
Why?
|
Base Sequence | 27 | 2022 | 4907 | 0.550 |
Why?
|
Child, Preschool | 51 | 2021 | 16816 | 0.540 |
Why?
|
Computational Biology | 16 | 2021 | 1279 | 0.530 |
Why?
|
Transcriptome | 10 | 2022 | 1946 | 0.530 |
Why?
|
Immunologic Deficiency Syndromes | 5 | 2020 | 242 | 0.530 |
Why?
|
Child | 65 | 2024 | 30264 | 0.530 |
Why?
|
Charcot-Marie-Tooth Disease | 5 | 2015 | 195 | 0.530 |
Why?
|
Insect Proteins | 5 | 2020 | 96 | 0.520 |
Why?
|
Heterozygote | 18 | 2020 | 1017 | 0.520 |
Why?
|
Genotype | 22 | 2024 | 4007 | 0.510 |
Why?
|
Genes, Insect | 6 | 2015 | 130 | 0.490 |
Why?
|
Haplotypes | 10 | 2024 | 821 | 0.480 |
Why?
|
Growth Disorders | 4 | 2018 | 220 | 0.480 |
Why?
|
Repressor Proteins | 8 | 2019 | 1692 | 0.480 |
Why?
|
Aging | 8 | 2016 | 1572 | 0.480 |
Why?
|
Adaptor Proteins, Signal Transducing | 8 | 2024 | 1455 | 0.470 |
Why?
|
Arthropods | 4 | 2020 | 26 | 0.470 |
Why?
|
Synteny | 12 | 2017 | 85 | 0.450 |
Why?
|
Heart Diseases | 6 | 2014 | 758 | 0.440 |
Why?
|
Infant | 37 | 2021 | 13825 | 0.440 |
Why?
|
Mammals | 5 | 2015 | 371 | 0.430 |
Why?
|
Anodontia | 3 | 2018 | 28 | 0.430 |
Why?
|
Gene Regulatory Networks | 4 | 2020 | 675 | 0.430 |
Why?
|
Transcription Factors | 15 | 2022 | 5345 | 0.430 |
Why?
|
Proteins | 10 | 2018 | 1977 | 0.430 |
Why?
|
Gene Expression Regulation | 12 | 2021 | 4063 | 0.430 |
Why?
|
Nervous System Diseases | 4 | 2019 | 522 | 0.420 |
Why?
|
DNA Mutational Analysis | 17 | 2021 | 2298 | 0.420 |
Why?
|
Genetic Markers | 3 | 2020 | 923 | 0.420 |
Why?
|
Developmental Disabilities | 6 | 2021 | 683 | 0.420 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 54 | 0.410 |
Why?
|
Heterotaxy Syndrome | 3 | 2024 | 65 | 0.410 |
Why?
|
Neurodevelopmental Disorders | 3 | 2022 | 442 | 0.410 |
Why?
|
Drosophila melanogaster | 9 | 2016 | 825 | 0.410 |
Why?
|
Y Chromosome | 3 | 2020 | 75 | 0.400 |
Why?
|
Microcephaly | 5 | 2023 | 328 | 0.400 |
Why?
|
Killer Cells, Natural | 4 | 2020 | 936 | 0.400 |
Why?
|
DNA-Binding Proteins | 14 | 2023 | 4881 | 0.390 |
Why?
|
Microfilament Proteins | 6 | 2018 | 496 | 0.390 |
Why?
|
Cohort Studies | 26 | 2024 | 9454 | 0.390 |
Why?
|
Chromosomes, Human, X | 6 | 2021 | 196 | 0.380 |
Why?
|
Mutation Rate | 6 | 2020 | 227 | 0.380 |
Why?
|
Gene Dosage | 10 | 2020 | 835 | 0.380 |
Why?
|
Selection, Genetic | 13 | 2020 | 185 | 0.380 |
Why?
|
Heart Defects, Congenital | 6 | 2024 | 1764 | 0.380 |
Why?
|
Codon, Nonsense | 7 | 2020 | 161 | 0.380 |
Why?
|
Micrognathism | 3 | 2016 | 67 | 0.370 |
Why?
|
Brain Neoplasms | 9 | 2023 | 4988 | 0.370 |
Why?
|
Genetics, Population | 10 | 2021 | 228 | 0.370 |
Why?
|
Host-Parasite Interactions | 4 | 2020 | 68 | 0.360 |
Why?
|
Musculoskeletal Abnormalities | 2 | 2022 | 78 | 0.350 |
Why?
|
DNA, Bacterial | 6 | 2012 | 571 | 0.350 |
Why?
|
DEAD-box RNA Helicases | 3 | 2022 | 260 | 0.350 |
Why?
|
Family | 8 | 2020 | 747 | 0.350 |
Why?
|
Carrier Proteins | 8 | 2023 | 2032 | 0.350 |
Why?
|
Adolescent | 44 | 2021 | 32385 | 0.340 |
Why?
|
Insecticide Resistance | 3 | 2020 | 28 | 0.340 |
Why?
|
Heteroptera | 2 | 2020 | 10 | 0.340 |
Why?
|
Amino Acid Sequence | 16 | 2020 | 4273 | 0.340 |
Why?
|
Fasting | 4 | 2016 | 355 | 0.340 |
Why?
|
Primates | 3 | 2020 | 132 | 0.330 |
Why?
|
Rhabdomyosarcoma | 2 | 2024 | 347 | 0.330 |
Why?
|
Gene Expression Profiling | 13 | 2021 | 5222 | 0.330 |
Why?
|
Genes, Recessive | 7 | 2022 | 197 | 0.330 |
Why?
|
Coatomer Protein | 2 | 2021 | 33 | 0.320 |
Why?
|
Smith-Magenis Syndrome | 3 | 2019 | 127 | 0.320 |
Why?
|
Cheirogaleidae | 2 | 2018 | 6 | 0.320 |
Why?
|
Genetic Linkage | 5 | 2019 | 424 | 0.310 |
Why?
|
Quantitative Trait Loci | 9 | 2020 | 339 | 0.310 |
Why?
|
Oxidoreductases | 3 | 2020 | 171 | 0.310 |
Why?
|
Atherosclerosis | 4 | 2019 | 968 | 0.310 |
Why?
|
Metagenomics | 4 | 2017 | 116 | 0.310 |
Why?
|
Biliary Atresia | 2 | 2023 | 198 | 0.310 |
Why?
|
Mosaicism | 3 | 2020 | 275 | 0.310 |
Why?
|
Genomic Instability | 3 | 2022 | 525 | 0.310 |
Why?
|
Genome, Protozoan | 2 | 2020 | 26 | 0.310 |
Why?
|
Lymphoproliferative Disorders | 2 | 2021 | 371 | 0.310 |
Why?
|
Adult | 58 | 2021 | 80647 | 0.310 |
Why?
|
Actins | 3 | 2020 | 615 | 0.300 |
Why?
|
Metalloendopeptidases | 3 | 2017 | 180 | 0.300 |
Why?
|
Comparative Genomic Hybridization | 9 | 2024 | 696 | 0.300 |
Why?
|
Arthrogryposis | 2 | 2019 | 34 | 0.300 |
Why?
|
Chromosomes, Mammalian | 4 | 2022 | 61 | 0.300 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2020 | 1279 | 0.300 |
Why?
|
Cell Cycle Proteins | 8 | 2020 | 2093 | 0.290 |
Why?
|
Genes, Dominant | 5 | 2020 | 331 | 0.290 |
Why?
|
Child Development Disorders, Pervasive | 3 | 2013 | 89 | 0.290 |
Why?
|
Lipids | 2 | 2021 | 659 | 0.290 |
Why?
|
Models, Genetic | 10 | 2020 | 1043 | 0.290 |
Why?
|
GTP Phosphohydrolases | 4 | 2019 | 340 | 0.290 |
Why?
|
Chromosome Disorders | 3 | 2019 | 418 | 0.290 |
Why?
|
Nuclear Proteins | 7 | 2020 | 3367 | 0.290 |
Why?
|
Multigene Family | 8 | 2020 | 422 | 0.290 |
Why?
|
Zebrafish | 11 | 2021 | 466 | 0.290 |
Why?
|
Young Adult | 30 | 2021 | 22201 | 0.290 |
Why?
|
Cell Adhesion Molecules | 4 | 2018 | 583 | 0.290 |
Why?
|
Glioma | 4 | 2023 | 1982 | 0.280 |
Why?
|
DNA, Complementary | 5 | 2021 | 881 | 0.280 |
Why?
|
Mitochondrial Proteins | 4 | 2017 | 379 | 0.280 |
Why?
|
Social Behavior | 3 | 2020 | 300 | 0.280 |
Why?
|
Optic Atrophy | 3 | 2016 | 47 | 0.280 |
Why?
|
Cilia | 2 | 2020 | 91 | 0.280 |
Why?
|
Linkage Disequilibrium | 9 | 2019 | 426 | 0.280 |
Why?
|
Gene Transfer, Horizontal | 5 | 2020 | 58 | 0.270 |
Why?
|
Genetic Speciation | 4 | 2020 | 28 | 0.270 |
Why?
|
Osteochondrodysplasias | 2 | 2019 | 73 | 0.270 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2019 | 185 | 0.270 |
Why?
|
Metabolome | 3 | 2019 | 350 | 0.270 |
Why?
|
Consanguinity | 5 | 2018 | 114 | 0.270 |
Why?
|
Infant, Newborn | 18 | 2023 | 8561 | 0.270 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2020 | 646 | 0.270 |
Why?
|
Polymorphism, Genetic | 8 | 2019 | 1425 | 0.270 |
Why?
|
Neurodegenerative Diseases | 3 | 2018 | 269 | 0.270 |
Why?
|
Sequence Alignment | 10 | 2015 | 844 | 0.270 |
Why?
|
Megalencephaly | 2 | 2016 | 57 | 0.270 |
Why?
|
Multifactorial Inheritance | 4 | 2021 | 149 | 0.270 |
Why?
|
Behavior, Animal | 3 | 2020 | 731 | 0.270 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2023 | 1556 | 0.260 |
Why?
|
X Chromosome | 5 | 2020 | 340 | 0.260 |
Why?
|
Malformations of Cortical Development | 3 | 2017 | 56 | 0.260 |
Why?
|
Genomic Structural Variation | 4 | 2024 | 85 | 0.260 |
Why?
|
Simian Immunodeficiency Virus | 2 | 2018 | 141 | 0.260 |
Why?
|
Bone Diseases, Developmental | 2 | 2017 | 67 | 0.260 |
Why?
|
Inheritance Patterns | 5 | 2018 | 135 | 0.260 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2021 | 341 | 0.260 |
Why?
|
Diptera | 2 | 2015 | 27 | 0.250 |
Why?
|
Immunity | 4 | 2021 | 359 | 0.250 |
Why?
|
Heart Conduction System | 2 | 2018 | 177 | 0.250 |
Why?
|
Lipid Metabolism | 3 | 2021 | 490 | 0.250 |
Why?
|
Dishevelled Proteins | 3 | 2020 | 55 | 0.250 |
Why?
|
Retinitis Pigmentosa | 3 | 2015 | 85 | 0.250 |
Why?
|
Proto-Oncogene Proteins | 5 | 2018 | 2562 | 0.250 |
Why?
|
Wasps | 2 | 2018 | 14 | 0.250 |
Why?
|
Syndrome | 9 | 2019 | 1382 | 0.240 |
Why?
|
Receptors, Odorant | 4 | 2020 | 46 | 0.240 |
Why?
|
Atrial Fibrillation | 3 | 2020 | 806 | 0.240 |
Why?
|
Bees | 2 | 2015 | 31 | 0.240 |
Why?
|
Genetic Heterogeneity | 4 | 2020 | 317 | 0.240 |
Why?
|
Genetics, Medical | 6 | 2020 | 141 | 0.240 |
Why?
|
DNA Methylation | 8 | 2021 | 2718 | 0.240 |
Why?
|
Gene Library | 7 | 2015 | 300 | 0.240 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2006 | 315 | 0.240 |
Why?
|
Chromosome Mapping | 9 | 2017 | 1428 | 0.240 |
Why?
|
Species Specificity | 9 | 2022 | 775 | 0.240 |
Why?
|
Health | 3 | 2020 | 55 | 0.240 |
Why?
|
Gastrointestinal Microbiome | 3 | 2018 | 953 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 1419 | 0.230 |
Why?
|
Minichromosome Maintenance Proteins | 2 | 2020 | 10 | 0.230 |
Why?
|
Chromosome Aberrations | 4 | 2019 | 1970 | 0.230 |
Why?
|
Gene Duplication | 5 | 2024 | 431 | 0.230 |
Why?
|
Centromere | 5 | 2017 | 95 | 0.230 |
Why?
|
Point Mutation | 3 | 2016 | 777 | 0.220 |
Why?
|
Muscle Weakness | 2 | 2016 | 115 | 0.220 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2023 | 23 | 0.220 |
Why?
|
Laboratories | 1 | 2024 | 140 | 0.210 |
Why?
|
Transposition of Great Vessels | 1 | 2024 | 129 | 0.210 |
Why?
|
Case-Control Studies | 12 | 2023 | 6017 | 0.210 |
Why?
|
Mice | 29 | 2023 | 35338 | 0.210 |
Why?
|
Yaws | 2 | 2012 | 5 | 0.210 |
Why?
|
Treponema pallidum | 2 | 2012 | 31 | 0.210 |
Why?
|
Blood Glucose | 3 | 2021 | 1273 | 0.210 |
Why?
|
Receptors, Cell Surface | 2 | 2018 | 884 | 0.210 |
Why?
|
Biomarkers, Tumor | 5 | 2023 | 10594 | 0.210 |
Why?
|
Factor VIII | 1 | 2022 | 78 | 0.210 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1041 | 0.200 |
Why?
|
Mesocricetus | 1 | 2022 | 116 | 0.200 |
Why?
|
Neoplasm Proteins | 4 | 2019 | 3273 | 0.200 |
Why?
|
Siblings | 4 | 2018 | 294 | 0.200 |
Why?
|
Conserved Sequence | 6 | 2020 | 465 | 0.200 |
Why?
|
Sertoli-Leydig Cell Tumor | 1 | 2022 | 20 | 0.200 |
Why?
|
Microbiota | 2 | 2019 | 552 | 0.200 |
Why?
|
Hernias, Diaphragmatic, Congenital | 2 | 2018 | 374 | 0.200 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2022 | 42 | 0.200 |
Why?
|
Hemostatics | 1 | 2022 | 82 | 0.200 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 2270 | 0.200 |
Why?
|
Cryptosporidium | 1 | 2022 | 46 | 0.200 |
Why?
|
Physical Chromosome Mapping | 3 | 2015 | 73 | 0.200 |
Why?
|
Neptune | 1 | 2021 | 6 | 0.200 |
Why?
|
Phosphoproteins | 3 | 2017 | 1175 | 0.200 |
Why?
|
Middle Aged | 38 | 2021 | 89359 | 0.200 |
Why?
|
Osteogenesis Imperfecta | 1 | 2023 | 137 | 0.200 |
Why?
|
Golgi Apparatus | 3 | 2021 | 144 | 0.200 |
Why?
|
Coat Protein Complex I | 1 | 2021 | 17 | 0.200 |
Why?
|
Cryptosporidium parvum | 1 | 2022 | 61 | 0.200 |
Why?
|
Proteogenomics | 1 | 2022 | 110 | 0.200 |
Why?
|
B-Lymphocytes | 2 | 2020 | 1351 | 0.200 |
Why?
|
Syphilis | 2 | 2012 | 65 | 0.200 |
Why?
|
Chromosomes | 3 | 2015 | 250 | 0.200 |
Why?
|
Genetic Fitness | 2 | 2018 | 39 | 0.200 |
Why?
|
Pest Control, Biological | 2 | 2018 | 14 | 0.190 |
Why?
|
Cryptosporidiosis | 1 | 2022 | 87 | 0.190 |
Why?
|
DNA Replication | 5 | 2019 | 750 | 0.190 |
Why?
|
Population Health | 1 | 2022 | 53 | 0.190 |
Why?
|
Genome, Viral | 3 | 2021 | 164 | 0.190 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2015 | 2507 | 0.190 |
Why?
|
Life History Traits | 1 | 2020 | 5 | 0.190 |
Why?
|
Thysanoptera | 1 | 2020 | 5 | 0.190 |
Why?
|
Macaca | 3 | 2018 | 100 | 0.190 |
Why?
|
Oncogenes | 3 | 2021 | 673 | 0.190 |
Why?
|
Human Migration | 1 | 2020 | 13 | 0.190 |
Why?
|
Transplants | 1 | 2021 | 53 | 0.190 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2015 | 399 | 0.190 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2020 | 23 | 0.190 |
Why?
|
Nerve Tissue Proteins | 4 | 2021 | 1479 | 0.180 |
Why?
|
Gene Silencing | 2 | 2014 | 839 | 0.180 |
Why?
|
Insulin | 3 | 2016 | 1473 | 0.180 |
Why?
|
Mutation Accumulation | 1 | 2020 | 1 | 0.180 |
Why?
|
Ribonuclease III | 1 | 2022 | 186 | 0.180 |
Why?
|
Amino Acid Substitution | 6 | 2020 | 657 | 0.180 |
Why?
|
Bone Marrow Transplantation | 2 | 2024 | 1615 | 0.180 |
Why?
|
Hymenoptera | 1 | 2020 | 8 | 0.180 |
Why?
|
Myxomycetes | 1 | 2020 | 4 | 0.180 |
Why?
|
Polyketide Synthases | 1 | 2020 | 6 | 0.180 |
Why?
|
Cercocebus atys | 2 | 2018 | 13 | 0.180 |
Why?
|
Insecticides | 3 | 2016 | 49 | 0.180 |
Why?
|
Common Variable Immunodeficiency | 1 | 2020 | 31 | 0.180 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 47 | 0.180 |
Why?
|
Immunologic Memory | 2 | 2020 | 376 | 0.180 |
Why?
|
Paternal Age | 1 | 2020 | 13 | 0.180 |
Why?
|
Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 68 | 0.180 |
Why?
|
Vesicular Transport Proteins | 2 | 2019 | 146 | 0.180 |
Why?
|
Coronary Disease | 2 | 2015 | 796 | 0.180 |
Why?
|
Social Skills | 1 | 2020 | 20 | 0.180 |
Why?
|
Mediator Complex | 2 | 2020 | 72 | 0.180 |
Why?
|
Circulating Tumor DNA | 1 | 2023 | 247 | 0.180 |
Why?
|
Genomic Imprinting | 2 | 2019 | 190 | 0.180 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2021 | 155 | 0.180 |
Why?
|
Pathology, Molecular | 2 | 2018 | 127 | 0.180 |
Why?
|
Healthy Volunteers | 2 | 2017 | 190 | 0.170 |
Why?
|
Molecular Chaperones | 2 | 2018 | 257 | 0.170 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2019 | 43 | 0.170 |
Why?
|
Arabs | 2 | 2016 | 37 | 0.170 |
Why?
|
Genes, X-Linked | 3 | 2016 | 67 | 0.170 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2019 | 32 | 0.170 |
Why?
|
Sodium-Glucose Transport Proteins | 1 | 2019 | 3 | 0.170 |
Why?
|
Mitochondria | 2 | 2016 | 1306 | 0.170 |
Why?
|
X Chromosome Inactivation | 2 | 2016 | 72 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 4 | 2023 | 1867 | 0.170 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2020 | 76 | 0.170 |
Why?
|
Hemiptera | 1 | 2019 | 9 | 0.170 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2022 | 211 | 0.170 |
Why?
|
Sequence Deletion | 7 | 2018 | 873 | 0.170 |
Why?
|
Gene Deletion | 3 | 2016 | 1470 | 0.170 |
Why?
|
RNA-Binding Proteins | 3 | 2022 | 1002 | 0.170 |
Why?
|
Polycystic Kidney Diseases | 1 | 2019 | 34 | 0.170 |
Why?
|
Osteoporosis | 1 | 2021 | 232 | 0.170 |
Why?
|
Protozoan Proteins | 1 | 2020 | 120 | 0.170 |
Why?
|
Wnt Signaling Pathway | 3 | 2020 | 440 | 0.170 |
Why?
|
Walker-Warburg Syndrome | 1 | 2018 | 6 | 0.170 |
Why?
|
Dictyostelium | 2 | 2015 | 126 | 0.170 |
Why?
|
Epigenesis, Genetic | 3 | 2021 | 1429 | 0.160 |
Why?
|
Tubulin | 2 | 2017 | 168 | 0.160 |
Why?
|
Papio | 1 | 2019 | 72 | 0.160 |
Why?
|
DNA | 4 | 2022 | 2732 | 0.160 |
Why?
|
Extracellular Matrix Proteins | 2 | 2018 | 310 | 0.160 |
Why?
|
Algorithms | 7 | 2022 | 3968 | 0.160 |
Why?
|
Cerebellar Ataxia | 1 | 2019 | 70 | 0.160 |
Why?
|
Primate Diseases | 1 | 2018 | 19 | 0.160 |
Why?
|
Blood Pressure | 2 | 2015 | 1521 | 0.160 |
Why?
|
Wnt Proteins | 2 | 2018 | 396 | 0.160 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2019 | 64 | 0.160 |
Why?
|
Pancreatic Neoplasms | 4 | 2021 | 5226 | 0.160 |
Why?
|
Population Groups | 3 | 2017 | 42 | 0.160 |
Why?
|
Deoxyglucose | 1 | 2019 | 116 | 0.160 |
Why?
|
C-Reactive Protein | 2 | 2019 | 552 | 0.160 |
Why?
|
Ependymoma | 1 | 2021 | 260 | 0.160 |
Why?
|
Organ Transplantation | 1 | 2021 | 202 | 0.160 |
Why?
|
RNA Helicases | 1 | 2019 | 104 | 0.160 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2019 | 187 | 0.160 |
Why?
|
NAV1.8 Voltage-Gated Sodium Channel | 1 | 2018 | 7 | 0.160 |
Why?
|
Amphipoda | 1 | 2018 | 4 | 0.160 |
Why?
|
Chromosome Breakage | 3 | 2008 | 224 | 0.160 |
Why?
|
Blattellidae | 1 | 2018 | 3 | 0.160 |
Why?
|
Isoptera | 1 | 2018 | 4 | 0.160 |
Why?
|
Transcription, Genetic | 4 | 2018 | 3147 | 0.160 |
Why?
|
RNA, Messenger | 9 | 2018 | 6218 | 0.160 |
Why?
|
Disease | 3 | 2014 | 161 | 0.160 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 239 | 0.160 |
Why?
|
Cytochrome P-450 CYP2A6 | 1 | 2018 | 14 | 0.160 |
Why?
|
Quantitative Trait, Heritable | 3 | 2014 | 91 | 0.160 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 457 | 0.150 |
Why?
|
Receptors, Interleukin | 1 | 2018 | 97 | 0.150 |
Why?
|
Nonsense Mediated mRNA Decay | 1 | 2018 | 38 | 0.150 |
Why?
|
Host Specificity | 1 | 2018 | 20 | 0.150 |
Why?
|
Hypertension | 3 | 2016 | 1577 | 0.150 |
Why?
|
Alternative Splicing | 3 | 2017 | 598 | 0.150 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2018 | 44 | 0.150 |
Why?
|
Bone and Bones | 1 | 2021 | 604 | 0.150 |
Why?
|
Microarray Analysis | 1 | 2019 | 394 | 0.150 |
Why?
|
Mycobiome | 1 | 2017 | 12 | 0.150 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2018 | 365 | 0.150 |
Why?
|
Exonucleases | 2 | 2015 | 50 | 0.150 |
Why?
|
Turkey | 4 | 2021 | 56 | 0.150 |
Why?
|
Water Pollutants, Chemical | 1 | 2018 | 38 | 0.150 |
Why?
|
Models, Molecular | 8 | 2019 | 1767 | 0.150 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 162 | 0.150 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2017 | 6 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2022 | 436 | 0.150 |
Why?
|
Spiders | 1 | 2017 | 8 | 0.150 |
Why?
|
Chromosomal Instability | 1 | 2019 | 231 | 0.150 |
Why?
|
Fibromatosis, Gingival | 1 | 2017 | 4 | 0.150 |
Why?
|
Cell Line | 6 | 2022 | 5120 | 0.150 |
Why?
|
Sheep | 1 | 2018 | 266 | 0.150 |
Why?
|
Multiprotein Complexes | 2 | 2016 | 386 | 0.150 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2019 | 286 | 0.150 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2019 | 246 | 0.150 |
Why?
|
Biodiversity | 2 | 2015 | 92 | 0.150 |
Why?
|
Eye Proteins | 2 | 2021 | 276 | 0.150 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2020 | 482 | 0.150 |
Why?
|
Clinical Protocols | 1 | 2020 | 471 | 0.150 |
Why?
|
CpG Islands | 6 | 2015 | 643 | 0.150 |
Why?
|
Chromosomes, Human, Y | 3 | 2014 | 52 | 0.150 |
Why?
|
Haploinsufficiency | 2 | 2021 | 299 | 0.150 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 625 | 0.150 |
Why?
|
Herpesvirus 4, Human | 2 | 2021 | 954 | 0.150 |
Why?
|
Signal Transduction | 13 | 2023 | 12119 | 0.150 |
Why?
|
Mobius Syndrome | 1 | 2017 | 8 | 0.150 |
Why?
|
Hemizygote | 1 | 2017 | 17 | 0.150 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 256 | 0.150 |
Why?
|
Fetus | 2 | 2018 | 623 | 0.150 |
Why?
|
Adenosine Triphosphatases | 2 | 2017 | 439 | 0.150 |
Why?
|
Longevity | 1 | 2018 | 154 | 0.150 |
Why?
|
Kidney Neoplasms | 3 | 2016 | 3106 | 0.140 |
Why?
|
Population Density | 5 | 2018 | 42 | 0.140 |
Why?
|
Ion Channel Gating | 1 | 2018 | 151 | 0.140 |
Why?
|
Survival of Motor Neuron 1 Protein | 1 | 2017 | 21 | 0.140 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2018 | 261 | 0.140 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2017 | 46 | 0.140 |
Why?
|
Liddle Syndrome | 1 | 2016 | 6 | 0.140 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2020 | 407 | 0.140 |
Why?
|
Ketoglutarate Dehydrogenase Complex | 1 | 2016 | 16 | 0.140 |
Why?
|
Schizophrenia | 1 | 2020 | 378 | 0.140 |
Why?
|
Ceratitis capitata | 1 | 2016 | 4 | 0.140 |
Why?
|
Cloning, Molecular | 3 | 2009 | 1225 | 0.140 |
Why?
|
Macaca fascicularis | 1 | 2017 | 140 | 0.140 |
Why?
|
Feeding Behavior | 3 | 2020 | 830 | 0.140 |
Why?
|
Adaptation, Physiological | 2 | 2018 | 364 | 0.140 |
Why?
|
Methyl-CpG-Binding Protein 2 | 2 | 2016 | 284 | 0.140 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2017 | 45 | 0.140 |
Why?
|
MAP Kinase Kinase 1 | 2 | 2014 | 164 | 0.140 |
Why?
|
Manduca | 1 | 2016 | 4 | 0.140 |
Why?
|
Coleoptera | 1 | 2016 | 19 | 0.140 |
Why?
|
Receptors, KIR | 1 | 2017 | 61 | 0.140 |
Why?
|
Epithelial Sodium Channels | 1 | 2016 | 31 | 0.140 |
Why?
|
Sequence Analysis, RNA | 3 | 2015 | 684 | 0.140 |
Why?
|
Disease Susceptibility | 1 | 2019 | 534 | 0.140 |
Why?
|
Situs Inversus | 1 | 2016 | 27 | 0.140 |
Why?
|
Sudden Infant Death | 1 | 2016 | 33 | 0.140 |
Why?
|
Muscle Proteins | 2 | 2017 | 565 | 0.140 |
Why?
|
Reproducibility of Results | 10 | 2021 | 6176 | 0.140 |
Why?
|
Spleen | 1 | 2019 | 692 | 0.140 |
Why?
|
Genetic Carrier Screening | 1 | 2017 | 87 | 0.140 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 71 | 0.140 |
Why?
|
Human Genome Project | 4 | 2015 | 61 | 0.140 |
Why?
|
Meningioma | 1 | 2019 | 297 | 0.140 |
Why?
|
Bardet-Biedl Syndrome | 2 | 2014 | 39 | 0.140 |
Why?
|
Amino Acids | 2 | 2016 | 760 | 0.140 |
Why?
|
Fungi | 1 | 2017 | 145 | 0.140 |
Why?
|
Ectoparasitic Infestations | 1 | 2016 | 4 | 0.140 |
Why?
|
Gene Flow | 3 | 2020 | 15 | 0.140 |
Why?
|
Psychomotor Disorders | 1 | 2016 | 30 | 0.140 |
Why?
|
Bedbugs | 1 | 2016 | 6 | 0.140 |
Why?
|
Polyhydramnios | 1 | 2016 | 35 | 0.140 |
Why?
|
Mutagenesis | 3 | 2015 | 481 | 0.140 |
Why?
|
Feeding and Eating Disorders | 1 | 2017 | 94 | 0.140 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2018 | 1706 | 0.130 |
Why?
|
GTPase-Activating Proteins | 1 | 2016 | 127 | 0.130 |
Why?
|
Irritable Bowel Syndrome | 1 | 2019 | 206 | 0.130 |
Why?
|
Platelet Aggregation | 1 | 2017 | 260 | 0.130 |
Why?
|
Smell | 2 | 2019 | 131 | 0.130 |
Why?
|
Chordata, Nonvertebrate | 1 | 2015 | 5 | 0.130 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 196 | 0.130 |
Why?
|
Geminin | 1 | 2015 | 9 | 0.130 |
Why?
|
Death, Sudden | 1 | 2016 | 59 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 547 | 0.130 |
Why?
|
Waardenburg Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
Hearing Loss, Unilateral | 1 | 2015 | 7 | 0.130 |
Why?
|
Virus Replication | 2 | 2022 | 716 | 0.130 |
Why?
|
Cattle | 3 | 2020 | 792 | 0.130 |
Why?
|
Hypogonadism | 2 | 2019 | 256 | 0.130 |
Why?
|
Lipoprotein(a) | 1 | 2017 | 121 | 0.130 |
Why?
|
Gene Rearrangement | 7 | 2019 | 796 | 0.130 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2016 | 83 | 0.130 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2016 | 96 | 0.130 |
Why?
|
Genetic Load | 1 | 2015 | 5 | 0.130 |
Why?
|
Congenital Microtia | 1 | 2015 | 16 | 0.130 |
Why?
|
Tenascin | 1 | 2016 | 53 | 0.130 |
Why?
|
Transposases | 1 | 2016 | 68 | 0.130 |
Why?
|
Patella | 1 | 2015 | 41 | 0.130 |
Why?
|
Klippel-Feil Syndrome | 1 | 2015 | 11 | 0.130 |
Why?
|
RNA Interference | 3 | 2018 | 1409 | 0.130 |
Why?
|
Stem Cell Factor | 1 | 2015 | 89 | 0.130 |
Why?
|
NADP Transhydrogenase, AB-Specific | 1 | 2015 | 4 | 0.130 |
Why?
|
Epilepsy | 2 | 2016 | 933 | 0.130 |
Why?
|
Polyneuropathies | 1 | 2015 | 28 | 0.130 |
Why?
|
Cholesterol, HDL | 2 | 2017 | 360 | 0.130 |
Why?
|
RNA, Transfer | 2 | 2014 | 80 | 0.130 |
Why?
|
Chloride Channels | 1 | 2015 | 66 | 0.130 |
Why?
|
Brain Edema | 1 | 2016 | 88 | 0.130 |
Why?
|
Rhabdomyolysis | 1 | 2016 | 53 | 0.130 |
Why?
|
Mendelian Randomization Analysis | 1 | 2015 | 77 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2016 | 95 | 0.130 |
Why?
|
Nicotine | 1 | 2018 | 257 | 0.130 |
Why?
|
Neoplasms, Second Primary | 1 | 2024 | 1368 | 0.130 |
Why?
|
Gene Expression | 4 | 2016 | 3574 | 0.130 |
Why?
|
Plant Tumors | 1 | 2015 | 4 | 0.130 |
Why?
|
DNA, Intergenic | 1 | 2015 | 21 | 0.130 |
Why?
|
Histidine Ammonia-Lyase | 1 | 2015 | 5 | 0.130 |
Why?
|
Myelin Proteins | 1 | 2015 | 92 | 0.130 |
Why?
|
Atrophy | 1 | 2016 | 270 | 0.130 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2016 | 74 | 0.130 |
Why?
|
Epistasis, Genetic | 2 | 2012 | 106 | 0.130 |
Why?
|
Cell Cycle | 3 | 2019 | 2111 | 0.130 |
Why?
|
Blood Platelets | 2 | 2017 | 740 | 0.130 |
Why?
|
Introns | 5 | 2017 | 433 | 0.130 |
Why?
|
Aged | 23 | 2020 | 72779 | 0.130 |
Why?
|
Triticum | 1 | 2015 | 33 | 0.130 |
Why?
|
Functional Laterality | 1 | 2016 | 314 | 0.130 |
Why?
|
Meningeal Neoplasms | 1 | 2019 | 460 | 0.130 |
Why?
|
Receptors, Notch | 2 | 2015 | 375 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 131 | 0.130 |
Why?
|
Cardiology | 1 | 2021 | 586 | 0.120 |
Why?
|
Homocystinuria | 1 | 2015 | 20 | 0.120 |
Why?
|
Autism Spectrum Disorder | 1 | 2020 | 375 | 0.120 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2015 | 44 | 0.120 |
Why?
|
Duodenal Neoplasms | 1 | 2016 | 140 | 0.120 |
Why?
|
Larva | 4 | 2016 | 279 | 0.120 |
Why?
|
Troponin T | 1 | 2017 | 273 | 0.120 |
Why?
|
Hylobates | 1 | 2014 | 11 | 0.120 |
Why?
|
Genes | 4 | 2009 | 473 | 0.120 |
Why?
|
De Lange Syndrome | 1 | 2015 | 43 | 0.120 |
Why?
|
Fetal Hemoglobin | 1 | 2014 | 36 | 0.120 |
Why?
|
Parkinsonian Disorders | 1 | 2016 | 79 | 0.120 |
Why?
|
Hypopituitarism | 1 | 2015 | 32 | 0.120 |
Why?
|
Forkhead Transcription Factors | 2 | 2016 | 771 | 0.120 |
Why?
|
Histidine | 1 | 2015 | 96 | 0.120 |
Why?
|
Mice, Knockout | 7 | 2020 | 5806 | 0.120 |
Why?
|
Sequence Analysis | 1 | 2014 | 72 | 0.120 |
Why?
|
Leprosy, Tuberculoid | 1 | 2014 | 11 | 0.120 |
Why?
|
Databases, Nucleic Acid | 2 | 2017 | 115 | 0.120 |
Why?
|
Cytomegalovirus | 1 | 2018 | 483 | 0.120 |
Why?
|
Receptors, Lipoprotein | 1 | 2014 | 16 | 0.120 |
Why?
|
Molluscum Contagiosum | 1 | 2014 | 11 | 0.120 |
Why?
|
Phosphoglucomutase | 1 | 2014 | 9 | 0.120 |
Why?
|
Cholesterol, LDL | 2 | 2017 | 581 | 0.120 |
Why?
|
Cyclin B | 1 | 2014 | 67 | 0.120 |
Why?
|
Fibrillar Collagens | 1 | 2014 | 18 | 0.120 |
Why?
|
Rumen | 1 | 2014 | 12 | 0.120 |
Why?
|
Leukemia | 1 | 2023 | 1670 | 0.120 |
Why?
|
Optic Atrophies, Hereditary | 1 | 2014 | 17 | 0.120 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2014 | 13 | 0.120 |
Why?
|
Sheep, Domestic | 1 | 2014 | 19 | 0.120 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2014 | 23 | 0.120 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2015 | 53 | 0.120 |
Why?
|
Oncogene Fusion | 1 | 2014 | 63 | 0.120 |
Why?
|
DNA Polymerase II | 1 | 2014 | 60 | 0.120 |
Why?
|
Founder Effect | 1 | 2014 | 40 | 0.120 |
Why?
|
Fractures, Bone | 1 | 2017 | 302 | 0.120 |
Why?
|
rab GTP-Binding Proteins | 1 | 2015 | 80 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2021 | 734 | 0.120 |
Why?
|
Lipomatosis | 1 | 2014 | 23 | 0.120 |
Why?
|
Noonan Syndrome | 1 | 2014 | 28 | 0.120 |
Why?
|
Pituitary Gland | 1 | 2015 | 149 | 0.120 |
Why?
|
Scoliosis | 1 | 2016 | 149 | 0.120 |
Why?
|
DNA Damage | 2 | 2020 | 1981 | 0.120 |
Why?
|
Telomere-Binding Proteins | 1 | 2014 | 84 | 0.120 |
Why?
|
Population Growth | 1 | 2013 | 7 | 0.120 |
Why?
|
Anophthalmos | 1 | 2014 | 24 | 0.120 |
Why?
|
Spasms, Infantile | 1 | 2016 | 166 | 0.120 |
Why?
|
Sezary Syndrome | 1 | 2015 | 163 | 0.120 |
Why?
|
Phosphotransferases | 1 | 2014 | 82 | 0.120 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2014 | 39 | 0.120 |
Why?
|
Karyotype | 1 | 2014 | 236 | 0.120 |
Why?
|
DNA Repair | 5 | 2020 | 1879 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 2016 | 218 | 0.120 |
Why?
|
NAV1.5 Voltage-Gated Sodium Channel | 1 | 2014 | 43 | 0.120 |
Why?
|
Population Dynamics | 2 | 2011 | 43 | 0.120 |
Why?
|
Introduced Species | 3 | 2020 | 22 | 0.120 |
Why?
|
Refsum Disease | 1 | 2013 | 4 | 0.120 |
Why?
|
Datasets as Topic | 3 | 2020 | 177 | 0.120 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1916 | 0.120 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2014 | 34 | 0.120 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2014 | 100 | 0.120 |
Why?
|
COUP Transcription Factor I | 1 | 2014 | 82 | 0.120 |
Why?
|
Arthritis | 1 | 2015 | 145 | 0.120 |
Why?
|
Loss of Heterozygosity | 2 | 2013 | 622 | 0.120 |
Why?
|
Vocal Cord Paralysis | 1 | 2015 | 87 | 0.120 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 2013 | 40 | 0.120 |
Why?
|
Pan troglodytes | 4 | 2012 | 203 | 0.110 |
Why?
|
Congenital Disorders of Glycosylation | 1 | 2014 | 39 | 0.110 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2014 | 108 | 0.110 |
Why?
|
Cytomegalovirus Infections | 1 | 2018 | 465 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 462 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 1059 | 0.110 |
Why?
|
Alopecia | 1 | 2014 | 126 | 0.110 |
Why?
|
Cardiomyopathies | 2 | 2016 | 624 | 0.110 |
Why?
|
Bone Density | 1 | 2016 | 470 | 0.110 |
Why?
|
Demography | 2 | 2013 | 451 | 0.110 |
Why?
|
Hydroxyurea | 1 | 2014 | 215 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2017 | 445 | 0.110 |
Why?
|
ADAM Proteins | 1 | 2014 | 136 | 0.110 |
Why?
|
Axons | 2 | 2016 | 413 | 0.110 |
Why?
|
Receptors, Interleukin-6 | 1 | 2013 | 66 | 0.110 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2014 | 246 | 0.110 |
Why?
|
Mucous Membrane | 1 | 2014 | 277 | 0.110 |
Why?
|
Metagenome | 2 | 2015 | 181 | 0.110 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2018 | 488 | 0.110 |
Why?
|
Central Nervous System Diseases | 1 | 2014 | 130 | 0.110 |
Why?
|
Hand Deformities, Congenital | 1 | 2014 | 89 | 0.110 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 111 | 0.110 |
Why?
|
Skin Neoplasms | 3 | 2015 | 4733 | 0.110 |
Why?
|
Rett Syndrome | 1 | 2016 | 258 | 0.110 |
Why?
|
Sirolimus | 1 | 2018 | 832 | 0.110 |
Why?
|
Macular Degeneration | 1 | 2015 | 123 | 0.110 |
Why?
|
Bone Marrow Diseases | 1 | 2014 | 184 | 0.110 |
Why?
|
Severity of Illness Index | 6 | 2022 | 4451 | 0.110 |
Why?
|
Connexins | 1 | 2013 | 81 | 0.110 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 162 | 0.110 |
Why?
|
Cluster Analysis | 4 | 2018 | 1079 | 0.110 |
Why?
|
Sleep Apnea Syndromes | 1 | 2014 | 86 | 0.110 |
Why?
|
Chromosome Deletion | 2 | 2014 | 1019 | 0.110 |
Why?
|
Hematopoiesis | 1 | 2016 | 579 | 0.110 |
Why?
|
United States | 11 | 2022 | 16283 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 1 | 2018 | 877 | 0.110 |
Why?
|
Clonal Evolution | 1 | 2015 | 254 | 0.110 |
Why?
|
Marfan Syndrome | 1 | 2015 | 158 | 0.110 |
Why?
|
Epilepsy, Generalized | 1 | 2013 | 74 | 0.110 |
Why?
|
Homeodomain Proteins | 2 | 2020 | 1148 | 0.110 |
Why?
|
Language Development Disorders | 1 | 2014 | 166 | 0.110 |
Why?
|
Virus Diseases | 1 | 2016 | 400 | 0.110 |
Why?
|
Granuloma | 1 | 2014 | 158 | 0.110 |
Why?
|
ATPases Associated with Diverse Cellular Activities | 3 | 2017 | 86 | 0.110 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2009 | 194 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2016 | 632 | 0.110 |
Why?
|
Chromosome Breakpoints | 3 | 2019 | 105 | 0.110 |
Why?
|
Ampicillin | 1 | 2012 | 59 | 0.110 |
Why?
|
Olfactory Receptor Neurons | 1 | 2012 | 25 | 0.110 |
Why?
|
Caenorhabditis elegans | 3 | 2023 | 270 | 0.110 |
Why?
|
Carcinoma, Renal Cell | 2 | 2016 | 2398 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2015 | 216 | 0.110 |
Why?
|
Genes, Tumor Suppressor | 3 | 2011 | 1098 | 0.110 |
Why?
|
RNA Editing | 2 | 2014 | 91 | 0.100 |
Why?
|
Patient Selection | 1 | 2020 | 2109 | 0.100 |
Why?
|
Pyrazoles | 1 | 2021 | 1525 | 0.100 |
Why?
|
Internet | 2 | 2014 | 725 | 0.100 |
Why?
|
RNA, Untranslated | 6 | 2014 | 244 | 0.100 |
Why?
|
Enterococcus faecium | 1 | 2012 | 47 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 401 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2015 | 424 | 0.100 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2022 | 1300 | 0.100 |
Why?
|
Brain Diseases | 1 | 2015 | 404 | 0.100 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2011 | 19 | 0.100 |
Why?
|
Pediatric Obesity | 1 | 2017 | 374 | 0.100 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2011 | 17 | 0.100 |
Why?
|
Macropodidae | 1 | 2011 | 12 | 0.100 |
Why?
|
NF-kappa B | 1 | 2019 | 1585 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2024 | 7867 | 0.100 |
Why?
|
Neoplasms | 6 | 2021 | 15685 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 590 | 0.100 |
Why?
|
Facies | 3 | 2018 | 150 | 0.100 |
Why?
|
Adhesins, Bacterial | 2 | 2009 | 84 | 0.100 |
Why?
|
Cell Line, Tumor | 8 | 2019 | 14864 | 0.100 |
Why?
|
Treponema | 1 | 2011 | 3 | 0.100 |
Why?
|
Arrhythmias, Cardiac | 1 | 2016 | 519 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2020 | 4173 | 0.100 |
Why?
|
Leber Congenital Amaurosis | 1 | 2011 | 30 | 0.100 |
Why?
|
Myosins | 1 | 2011 | 97 | 0.100 |
Why?
|
Lung | 3 | 2022 | 3224 | 0.100 |
Why?
|
Consensus Sequence | 1 | 2011 | 113 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 598 | 0.100 |
Why?
|
Face | 1 | 2014 | 286 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 412 | 0.100 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2011 | 88 | 0.100 |
Why?
|
Infant, Newborn, Diseases | 1 | 2013 | 189 | 0.100 |
Why?
|
Neck | 1 | 2014 | 392 | 0.100 |
Why?
|
Pongo abelii | 1 | 2011 | 3 | 0.100 |
Why?
|
Pongo pygmaeus | 1 | 2011 | 6 | 0.100 |
Why?
|
Hemostasis | 1 | 2012 | 108 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 10267 | 0.100 |
Why?
|
Fatal Outcome | 3 | 2020 | 834 | 0.100 |
Why?
|
Principal Component Analysis | 3 | 2019 | 224 | 0.100 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2017 | 1128 | 0.100 |
Why?
|
Ciliary Motility Disorders | 1 | 2011 | 15 | 0.100 |
Why?
|
Cells, Cultured | 6 | 2019 | 5671 | 0.100 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2015 | 619 | 0.100 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2011 | 86 | 0.100 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2011 | 137 | 0.090 |
Why?
|
Skin | 2 | 2014 | 1281 | 0.090 |
Why?
|
Ischemia | 1 | 2014 | 400 | 0.090 |
Why?
|
Fibroblasts | 4 | 2021 | 1693 | 0.090 |
Why?
|
Cytokines | 1 | 2020 | 2867 | 0.090 |
Why?
|
Colitis | 1 | 2014 | 339 | 0.090 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2014 | 286 | 0.090 |
Why?
|
Base Composition | 5 | 2014 | 90 | 0.090 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2011 | 32 | 0.090 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 350 | 0.090 |
Why?
|
Urinary Bladder | 1 | 2014 | 582 | 0.090 |
Why?
|
MicroRNAs | 7 | 2016 | 2950 | 0.090 |
Why?
|
Reproduction | 3 | 2020 | 257 | 0.090 |
Why?
|
Gardnerella vaginalis | 1 | 2010 | 9 | 0.090 |
Why?
|
Chromosome Inversion | 3 | 2006 | 181 | 0.090 |
Why?
|
Sensitivity and Specificity | 5 | 2021 | 5115 | 0.090 |
Why?
|
HEK293 Cells | 4 | 2017 | 1503 | 0.090 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2011 | 194 | 0.090 |
Why?
|
F-Box Proteins | 1 | 2011 | 102 | 0.090 |
Why?
|
Endoplasmic Reticulum Stress | 3 | 2018 | 198 | 0.090 |
Why?
|
Vaginosis, Bacterial | 1 | 2010 | 24 | 0.090 |
Why?
|
Spinocerebellar Ataxias | 1 | 2013 | 238 | 0.090 |
Why?
|
DNA Transposable Elements | 4 | 2020 | 226 | 0.090 |
Why?
|
Carcinoma | 2 | 2013 | 2596 | 0.090 |
Why?
|
Germ Cells | 2 | 2024 | 334 | 0.090 |
Why?
|
Alzheimer Disease | 1 | 2018 | 903 | 0.090 |
Why?
|
Anemia, Sickle Cell | 1 | 2014 | 370 | 0.090 |
Why?
|
Autophagy | 1 | 2016 | 927 | 0.090 |
Why?
|
beta-Lactamases | 1 | 2012 | 181 | 0.090 |
Why?
|
Biomedical Research | 2 | 2016 | 826 | 0.090 |
Why?
|
Cell Proliferation | 3 | 2020 | 7304 | 0.090 |
Why?
|
Drosophila Proteins | 1 | 2016 | 865 | 0.090 |
Why?
|
Recombination, Genetic | 4 | 2019 | 618 | 0.090 |
Why?
|
Base Pairing | 1 | 2010 | 71 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2024 | 3244 | 0.090 |
Why?
|
Dystonic Disorders | 1 | 2011 | 82 | 0.090 |
Why?
|
Patient Care | 1 | 2011 | 152 | 0.090 |
Why?
|
Body Mass Index | 2 | 2017 | 2280 | 0.090 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 501 | 0.090 |
Why?
|
Colon | 1 | 2014 | 676 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2014 | 1330 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2015 | 866 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2015 | 9038 | 0.090 |
Why?
|
Real-Time Polymerase Chain Reaction | 3 | 2021 | 1230 | 0.090 |
Why?
|
Crossing Over, Genetic | 3 | 2020 | 56 | 0.090 |
Why?
|
Brain | 3 | 2021 | 4211 | 0.090 |
Why?
|
Risk Factors | 8 | 2022 | 18013 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2011 | 221 | 0.090 |
Why?
|
Ion Channels | 1 | 2011 | 228 | 0.090 |
Why?
|
NIH 3T3 Cells | 2 | 2023 | 262 | 0.090 |
Why?
|
Primary Myelofibrosis | 1 | 2018 | 891 | 0.090 |
Why?
|
Genotyping Techniques | 3 | 2016 | 157 | 0.090 |
Why?
|
Drosophila | 3 | 2016 | 852 | 0.090 |
Why?
|
Prognosis | 8 | 2021 | 22258 | 0.090 |
Why?
|
Expressed Sequence Tags | 2 | 2006 | 105 | 0.080 |
Why?
|
Mannosidases | 1 | 2009 | 20 | 0.080 |
Why?
|
Fimbriae, Bacterial | 1 | 2009 | 65 | 0.080 |
Why?
|
Protein Biosynthesis | 2 | 2014 | 915 | 0.080 |
Why?
|
Calcium-Binding Proteins | 2 | 2023 | 538 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 368 | 0.080 |
Why?
|
Contig Mapping | 2 | 2006 | 58 | 0.080 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 41 | 0.080 |
Why?
|
Streptococcus | 1 | 2009 | 73 | 0.080 |
Why?
|
RNA Splicing | 3 | 2016 | 375 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2014 | 5494 | 0.080 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2008 | 11 | 0.080 |
Why?
|
Interspersed Repetitive Sequences | 3 | 2015 | 34 | 0.080 |
Why?
|
Moyamoya Disease | 1 | 2009 | 42 | 0.080 |
Why?
|
Microsatellite Repeats | 3 | 2019 | 589 | 0.080 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 27 | 0.080 |
Why?
|
Aged, 80 and over | 10 | 2020 | 30764 | 0.080 |
Why?
|
Disease Progression | 5 | 2020 | 6885 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3623 | 0.080 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 74 | 0.080 |
Why?
|
Connectin | 2 | 2019 | 32 | 0.080 |
Why?
|
Autistic Disorder | 1 | 2012 | 334 | 0.080 |
Why?
|
Seizures | 1 | 2014 | 999 | 0.080 |
Why?
|
LIM Domain Proteins | 2 | 2020 | 110 | 0.080 |
Why?
|
Tribolium | 1 | 2008 | 7 | 0.080 |
Why?
|
Embryonic Development | 3 | 2019 | 318 | 0.080 |
Why?
|
Retinal Degeneration | 1 | 2009 | 94 | 0.080 |
Why?
|
Papillomavirus Infections | 2 | 2014 | 1009 | 0.080 |
Why?
|
Enterococcus faecalis | 1 | 2008 | 55 | 0.080 |
Why?
|
Endoribonucleases | 2 | 2022 | 108 | 0.080 |
Why?
|
Chromatin | 4 | 2016 | 969 | 0.080 |
Why?
|
Liver Failure | 1 | 2009 | 142 | 0.080 |
Why?
|
Repetitive Sequences, Nucleic Acid | 5 | 2008 | 360 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 2012 | 393 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2016 | 4769 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 1799 | 0.080 |
Why?
|
MutL Protein Homolog 1 | 2 | 2022 | 200 | 0.080 |
Why?
|
Embryo, Nonmammalian | 2 | 2021 | 228 | 0.080 |
Why?
|
Sequence Homology | 3 | 2015 | 72 | 0.080 |
Why?
|
Biomarkers | 2 | 2016 | 5158 | 0.080 |
Why?
|
Drug Resistance, Bacterial | 2 | 2008 | 422 | 0.080 |
Why?
|
Heart | 1 | 2014 | 1260 | 0.080 |
Why?
|
Genome Size | 2 | 2020 | 16 | 0.080 |
Why?
|
DNA, Mitochondrial | 4 | 2014 | 316 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2013 | 726 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 2 | 2023 | 530 | 0.070 |
Why?
|
Bacillus | 1 | 2007 | 36 | 0.070 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2019 | 203 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 909 | 0.070 |
Why?
|
Genes, Neoplasm | 1 | 2008 | 325 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2013 | 1112 | 0.070 |
Why?
|
Chromosome Duplication | 2 | 2019 | 158 | 0.070 |
Why?
|
Strongylocentrotus purpuratus | 1 | 2006 | 12 | 0.070 |
Why?
|
Mannheimia haemolytica | 1 | 2006 | 4 | 0.070 |
Why?
|
Transformation, Bacterial | 1 | 2006 | 16 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 3660 | 0.070 |
Why?
|
Endoplasmic Reticulum | 2 | 2021 | 316 | 0.070 |
Why?
|
Genes, Bacterial | 4 | 2010 | 237 | 0.070 |
Why?
|
Embryo, Mammalian | 3 | 2016 | 752 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 3616 | 0.070 |
Why?
|
Chemoreceptor Cells | 2 | 2017 | 16 | 0.070 |
Why?
|
Hydrogen Peroxide | 1 | 2007 | 222 | 0.070 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2011 | 508 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2021 | 1507 | 0.070 |
Why?
|
Organ Specificity | 2 | 2020 | 701 | 0.070 |
Why?
|
Testis | 3 | 2020 | 738 | 0.070 |
Why?
|
Feasibility Studies | 2 | 2023 | 2361 | 0.070 |
Why?
|
Homeostasis | 1 | 2011 | 945 | 0.070 |
Why?
|
Genome, Mitochondrial | 2 | 2017 | 37 | 0.070 |
Why?
|
Rats | 6 | 2016 | 6217 | 0.070 |
Why?
|
Surveys and Questionnaires | 1 | 2018 | 5934 | 0.070 |
Why?
|
Escherichia coli | 2 | 2012 | 1217 | 0.070 |
Why?
|
Bipolar Disorder | 1 | 2009 | 374 | 0.070 |
Why?
|
Nucleotide Motifs | 2 | 2016 | 61 | 0.070 |
Why?
|
Chromosome Segregation | 2 | 2017 | 81 | 0.070 |
Why?
|
Anxiety | 1 | 2013 | 1248 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4714 | 0.070 |
Why?
|
Proteomics | 2 | 2023 | 1423 | 0.060 |
Why?
|
Platelet Count | 2 | 2017 | 494 | 0.060 |
Why?
|
Selenoproteins | 2 | 2015 | 17 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2016 | 2142 | 0.060 |
Why?
|
ras Proteins | 3 | 2014 | 783 | 0.060 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 2 | 2016 | 271 | 0.060 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2006 | 172 | 0.060 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 2597 | 0.060 |
Why?
|
Glucose | 1 | 2011 | 1268 | 0.060 |
Why?
|
India | 3 | 2011 | 307 | 0.060 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2018 | 501 | 0.060 |
Why?
|
Protein Structure, Tertiary | 3 | 2014 | 1505 | 0.060 |
Why?
|
MAP Kinase Signaling System | 3 | 2014 | 883 | 0.060 |
Why?
|
Cytoskeletal Proteins | 2 | 2020 | 524 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2017 | 2340 | 0.060 |
Why?
|
Rickettsia typhi | 1 | 2004 | 12 | 0.060 |
Why?
|
Feces | 2 | 2019 | 815 | 0.060 |
Why?
|
Genetic Therapy | 1 | 2012 | 1630 | 0.060 |
Why?
|
Mutant Proteins | 2 | 2018 | 237 | 0.060 |
Why?
|
Neural Conduction | 2 | 2015 | 112 | 0.060 |
Why?
|
Parents | 2 | 2023 | 1054 | 0.060 |
Why?
|
Breeding | 2 | 2018 | 29 | 0.060 |
Why?
|
Workflow | 2 | 2017 | 288 | 0.060 |
Why?
|
Vision, Ocular | 2 | 2020 | 157 | 0.060 |
Why?
|
Myocardial Infarction | 1 | 2014 | 1471 | 0.060 |
Why?
|
Rats, Inbred BN | 1 | 2004 | 36 | 0.060 |
Why?
|
Animals, Genetically Modified | 2 | 2016 | 407 | 0.060 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2018 | 277 | 0.060 |
Why?
|
Sequence Homology, Nucleic Acid | 3 | 2011 | 355 | 0.060 |
Why?
|
Microscopy, Confocal | 2 | 2018 | 678 | 0.060 |
Why?
|
Genetic Complementation Test | 2 | 2015 | 131 | 0.060 |
Why?
|
Insecta | 2 | 2017 | 76 | 0.060 |
Why?
|
Japan | 2 | 2014 | 227 | 0.060 |
Why?
|
Peptides | 3 | 2017 | 1502 | 0.060 |
Why?
|
Gene Amplification | 2 | 2020 | 744 | 0.060 |
Why?
|
Protein Stability | 2 | 2015 | 372 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2016 | 7098 | 0.060 |
Why?
|
Sarcoma | 1 | 2014 | 1827 | 0.060 |
Why?
|
Body Patterning | 2 | 2019 | 214 | 0.060 |
Why?
|
Protein Transport | 2 | 2017 | 741 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 2218 | 0.060 |
Why?
|
Sequence Homology, Amino Acid | 2 | 2016 | 1001 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2012 | 2257 | 0.060 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 558 | 0.060 |
Why?
|
Immunophenotyping | 2 | 2018 | 1701 | 0.060 |
Why?
|
Euchromatin | 1 | 2002 | 15 | 0.050 |
Why?
|
Gene Order | 2 | 2014 | 111 | 0.050 |
Why?
|
Codon, Terminator | 1 | 2023 | 42 | 0.050 |
Why?
|
Biopsy | 2 | 2021 | 3497 | 0.050 |
Why?
|
Prospective Studies | 4 | 2024 | 13305 | 0.050 |
Why?
|
Iran | 1 | 2023 | 73 | 0.050 |
Why?
|
X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 63 | 0.050 |
Why?
|
RNA, Ribosomal | 1 | 2003 | 85 | 0.050 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2016 | 367 | 0.050 |
Why?
|
Factor VII | 1 | 2022 | 20 | 0.050 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 3662 | 0.050 |
Why?
|
Qa-SNARE Proteins | 1 | 2022 | 36 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2015 | 3952 | 0.050 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2022 | 48 | 0.050 |
Why?
|
Family Health | 2 | 2015 | 316 | 0.050 |
Why?
|
Loss of Function Mutation | 1 | 2023 | 149 | 0.050 |
Why?
|
Binding Sites | 2 | 2019 | 2207 | 0.050 |
Why?
|
Arteries | 1 | 2024 | 282 | 0.050 |
Why?
|
Gastrointestinal Tract | 2 | 2019 | 326 | 0.050 |
Why?
|
Heart Failure | 1 | 2016 | 2671 | 0.050 |
Why?
|
Nucleotides | 1 | 2022 | 163 | 0.050 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 45 | 0.050 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2009 | 618 | 0.050 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2021 | 852 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 174 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 224 | 0.050 |
Why?
|
Radiography | 2 | 2018 | 1944 | 0.050 |
Why?
|
Calcium Channels | 2 | 2014 | 199 | 0.050 |
Why?
|
A549 Cells | 1 | 2022 | 131 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2007 | 677 | 0.050 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 1699 | 0.050 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2015 | 463 | 0.050 |
Why?
|
Pharmacogenomic Testing | 1 | 2021 | 46 | 0.050 |
Why?
|
Pilot Projects | 3 | 2017 | 2870 | 0.050 |
Why?
|
Fibrinogen | 1 | 2022 | 208 | 0.050 |
Why?
|
Transcription Initiation Site | 2 | 2014 | 51 | 0.050 |
Why?
|
Receptor, trkB | 1 | 2021 | 53 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2018 | 11578 | 0.050 |
Why?
|
Microsatellite Instability | 2 | 2014 | 415 | 0.050 |
Why?
|
Protein Conformation | 2 | 2014 | 1270 | 0.050 |
Why?
|
Cercopithecidae | 1 | 2020 | 10 | 0.050 |
Why?
|
Telomerase | 2 | 2014 | 533 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2012 | 1800 | 0.050 |
Why?
|
Fossils | 1 | 2020 | 14 | 0.050 |
Why?
|
Immune Evasion | 1 | 2021 | 77 | 0.050 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2022 | 217 | 0.050 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 63 | 0.050 |
Why?
|
Turner Syndrome | 2 | 2014 | 70 | 0.050 |
Why?
|
Crops, Agricultural | 1 | 2020 | 15 | 0.050 |
Why?
|
Ascorbic Acid | 1 | 2021 | 126 | 0.050 |
Why?
|
Food Chain | 1 | 2020 | 11 | 0.050 |
Why?
|
Protein Inhibitors of Activated STAT | 1 | 2020 | 25 | 0.050 |
Why?
|
Peru | 1 | 2020 | 57 | 0.050 |
Why?
|
Telomere | 3 | 2012 | 516 | 0.050 |
Why?
|
Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 7 | 0.050 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2020 | 7 | 0.050 |
Why?
|
History, Ancient | 1 | 2020 | 67 | 0.050 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2020 | 25 | 0.050 |
Why?
|
Herbivory | 1 | 2020 | 7 | 0.050 |
Why?
|
Rare Diseases | 1 | 2024 | 360 | 0.050 |
Why?
|
Bacteria | 2 | 2019 | 626 | 0.050 |
Why?
|
Immunity, Innate | 2 | 2020 | 700 | 0.050 |
Why?
|
Models, Immunological | 1 | 2020 | 81 | 0.050 |
Why?
|
Metabolism | 1 | 2020 | 54 | 0.050 |
Why?
|
Collagen Type I | 1 | 2021 | 191 | 0.050 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2020 | 54 | 0.050 |
Why?
|
Receptors, Dopamine D2 | 1 | 2020 | 64 | 0.050 |
Why?
|
Phosphorylation | 2 | 2020 | 4881 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 1094 | 0.050 |
Why?
|
Africa | 1 | 2020 | 145 | 0.050 |
Why?
|
Amines | 1 | 2020 | 84 | 0.050 |
Why?
|
Age of Onset | 2 | 2015 | 811 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2020 | 39585 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5430 | 0.050 |
Why?
|
Retroelements | 2 | 2014 | 50 | 0.050 |
Why?
|
Islets of Langerhans | 1 | 2021 | 232 | 0.040 |
Why?
|
Cytidine Deaminase | 1 | 2020 | 83 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 279 | 0.040 |
Why?
|
Stroke | 1 | 2009 | 1180 | 0.040 |
Why?
|
Sex Chromosomes | 2 | 2014 | 41 | 0.040 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2022 | 227 | 0.040 |
Why?
|
Independent Living | 1 | 2020 | 72 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2022 | 351 | 0.040 |
Why?
|
Visual Acuity | 2 | 2015 | 857 | 0.040 |
Why?
|
Liver | 2 | 2021 | 2988 | 0.040 |
Why?
|
RNA Splice Sites | 2 | 2014 | 113 | 0.040 |
Why?
|
Mutagenesis, Insertional | 2 | 2014 | 218 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 14521 | 0.040 |
Why?
|
Neurons | 3 | 2016 | 2404 | 0.040 |
Why?
|
Molecular Conformation | 1 | 2019 | 171 | 0.040 |
Why?
|
Autoimmunity | 1 | 2021 | 273 | 0.040 |
Why?
|
Carboplatin | 1 | 2022 | 844 | 0.040 |
Why?
|
Bacterial Proteins | 3 | 2010 | 1047 | 0.040 |
Why?
|
CYS2-HIS2 Zinc Fingers | 1 | 2019 | 9 | 0.040 |
Why?
|
Epigenomics | 1 | 2021 | 269 | 0.040 |
Why?
|
Viral Load | 1 | 2021 | 488 | 0.040 |
Why?
|
Hybridization, Genetic | 1 | 2019 | 17 | 0.040 |
Why?
|
Pigmentation | 1 | 2019 | 44 | 0.040 |
Why?
|
Ecosystem | 1 | 2020 | 110 | 0.040 |
Why?
|
Limit of Detection | 1 | 2019 | 83 | 0.040 |
Why?
|
Protein Isoforms | 2 | 2014 | 848 | 0.040 |
Why?
|
Ankyrins | 1 | 2020 | 108 | 0.040 |
Why?
|
Geography | 2 | 2010 | 142 | 0.040 |
Why?
|
Peroxidases | 1 | 2019 | 29 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2020 | 276 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 2860 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 4860 | 0.040 |
Why?
|
Drug Resistance | 1 | 2020 | 597 | 0.040 |
Why?
|
Firmicutes | 1 | 2018 | 22 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 1377 | 0.040 |
Why?
|
Pets | 1 | 2018 | 21 | 0.040 |
Why?
|
Aotidae | 1 | 2018 | 29 | 0.040 |
Why?
|
Ecotoxicology | 1 | 2018 | 2 | 0.040 |
Why?
|
Transplant Recipients | 1 | 2021 | 334 | 0.040 |
Why?
|
Geologic Sediments | 1 | 2018 | 7 | 0.040 |
Why?
|
Cytochrome P450 Family 4 | 1 | 2018 | 6 | 0.040 |
Why?
|
Genes, Homeobox | 1 | 2019 | 149 | 0.040 |
Why?
|
Gonadal Dysgenesis, 46,XY | 1 | 2018 | 25 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2019 | 271 | 0.040 |
Why?
|
Obesity | 1 | 2011 | 2979 | 0.040 |
Why?
|
RNA, Viral | 1 | 2021 | 690 | 0.040 |
Why?
|
Receptor, Notch2 | 1 | 2018 | 23 | 0.040 |
Why?
|
Moths | 1 | 2018 | 36 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2022 | 694 | 0.040 |
Why?
|
Glucose Transport Proteins, Facilitative | 1 | 2018 | 27 | 0.040 |
Why?
|
Models, Animal | 2 | 2016 | 689 | 0.040 |
Why?
|
DNA Primers | 2 | 2015 | 1413 | 0.040 |
Why?
|
Perception | 1 | 2020 | 357 | 0.040 |
Why?
|
Bifidobacterium | 1 | 2018 | 58 | 0.040 |
Why?
|
Age Factors | 2 | 2020 | 5497 | 0.040 |
Why?
|
Plasmids | 3 | 2007 | 840 | 0.040 |
Why?
|
Biophysical Phenomena | 1 | 2018 | 114 | 0.040 |
Why?
|
G1 Phase Cell Cycle Checkpoints | 1 | 2018 | 45 | 0.040 |
Why?
|
Language | 1 | 2020 | 326 | 0.040 |
Why?
|
Malassezia | 1 | 2017 | 7 | 0.040 |
Why?
|
Saccharomyces | 1 | 2017 | 13 | 0.040 |
Why?
|
DNA, Ribosomal Spacer | 1 | 2017 | 14 | 0.040 |
Why?
|
Immunological Synapses | 1 | 2018 | 32 | 0.040 |
Why?
|
Toxicity Tests | 1 | 2018 | 52 | 0.040 |
Why?
|
Uterus | 1 | 2023 | 704 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 234 | 0.040 |
Why?
|
Down-Regulation | 1 | 2023 | 2112 | 0.040 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2017 | 22 | 0.040 |
Why?
|
Infant Care | 1 | 2017 | 47 | 0.040 |
Why?
|
Tissue Banks | 1 | 2018 | 51 | 0.040 |
Why?
|
Kelch-Like ECH-Associated Protein 1 | 1 | 2018 | 107 | 0.040 |
Why?
|
Protein Binding | 2 | 2019 | 3477 | 0.040 |
Why?
|
Crustacea | 1 | 2017 | 4 | 0.040 |
Why?
|
Copepoda | 1 | 2017 | 6 | 0.040 |
Why?
|
Brain Stem | 1 | 2018 | 177 | 0.040 |
Why?
|
Autoantibodies | 1 | 2021 | 584 | 0.040 |
Why?
|
Cardiac Myosins | 1 | 2017 | 19 | 0.040 |
Why?
|
Virulence | 2 | 2010 | 333 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2018 | 113 | 0.040 |
Why?
|
Tropomyosin | 1 | 2017 | 39 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2018 | 221 | 0.040 |
Why?
|
Cell Lineage | 1 | 2020 | 705 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2020 | 15242 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1082 | 0.040 |
Why?
|
North America | 1 | 2018 | 336 | 0.040 |
Why?
|
Heart Atria | 1 | 2020 | 372 | 0.040 |
Why?
|
Survival of Motor Neuron 2 Protein | 1 | 2017 | 13 | 0.040 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2017 | 32 | 0.040 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 116 | 0.040 |
Why?
|
Kallikreins | 1 | 2017 | 87 | 0.040 |
Why?
|
Gametogenesis | 1 | 2017 | 27 | 0.040 |
Why?
|
Promoter Regions, Genetic | 2 | 2014 | 3093 | 0.040 |
Why?
|
Models, Statistical | 2 | 2014 | 1163 | 0.040 |
Why?
|
Waist Circumference | 1 | 2017 | 99 | 0.040 |
Why?
|
Trees | 1 | 2016 | 16 | 0.040 |
Why?
|
Eye Diseases, Hereditary | 1 | 2017 | 32 | 0.040 |
Why?
|
Massachusetts | 1 | 2017 | 124 | 0.040 |
Why?
|
Ketoglutaric Acids | 1 | 2016 | 40 | 0.040 |
Why?
|
Viremia | 1 | 2018 | 181 | 0.040 |
Why?
|
Myosin Heavy Chains | 1 | 2017 | 131 | 0.040 |
Why?
|
Femur Neck | 1 | 2016 | 22 | 0.040 |
Why?
|
Amiloride | 1 | 2016 | 47 | 0.040 |
Why?
|
Oryzias | 1 | 2016 | 11 | 0.040 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 247 | 0.040 |
Why?
|
Receptors, Glucocorticoid | 1 | 2018 | 198 | 0.040 |
Why?
|
MEF2 Transcription Factors | 1 | 2016 | 49 | 0.040 |
Why?
|
Adenosine Diphosphate | 1 | 2017 | 116 | 0.040 |
Why?
|
Eye | 1 | 2018 | 289 | 0.040 |
Why?
|
Pupa | 1 | 2016 | 21 | 0.040 |
Why?
|
Breast Feeding | 1 | 2018 | 249 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 59 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2016 | 41 | 0.040 |
Why?
|
Ocular Motility Disorders | 1 | 2017 | 46 | 0.040 |
Why?
|
Interferon Type I | 1 | 2018 | 261 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 992 | 0.040 |
Why?
|
CD56 Antigen | 1 | 2016 | 84 | 0.030 |
Why?
|
PAX2 Transcription Factor | 1 | 2016 | 44 | 0.030 |
Why?
|
Bayes Theorem | 2 | 2011 | 1042 | 0.030 |
Why?
|
Tissue Donors | 1 | 2021 | 799 | 0.030 |
Why?
|
Ophthalmoplegia | 1 | 2017 | 75 | 0.030 |
Why?
|
Phosphorus | 1 | 2017 | 67 | 0.030 |
Why?
|
Renin | 1 | 2016 | 95 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2017 | 61 | 0.030 |
Why?
|
Aldosterone | 1 | 2016 | 75 | 0.030 |
Why?
|
Hydrochlorothiazide | 1 | 2016 | 65 | 0.030 |
Why?
|
National Human Genome Research Institute (U.S.) | 1 | 2016 | 17 | 0.030 |
Why?
|
DNA Helicases | 1 | 2019 | 449 | 0.030 |
Why?
|
Glycoproteins | 1 | 2020 | 758 | 0.030 |
Why?
|
Hypokalemia | 1 | 2016 | 57 | 0.030 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 252 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2017 | 161 | 0.030 |
Why?
|
HIV | 1 | 2018 | 233 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 36 | 0.030 |
Why?
|
Magnesium | 1 | 2017 | 163 | 0.030 |
Why?
|
Diagnosis | 1 | 2016 | 34 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2021 | 1114 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 231 | 0.030 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 209 | 0.030 |
Why?
|
Antipsychotic Agents | 1 | 2020 | 430 | 0.030 |
Why?
|
Candida | 1 | 2017 | 168 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2019 | 376 | 0.030 |
Why?
|
Echinodermata | 1 | 2015 | 6 | 0.030 |
Why?
|
Wnt-5a Protein | 1 | 2016 | 45 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2021 | 1804 | 0.030 |
Why?
|
Endoplasmic Reticulum-Associated Degradation | 1 | 2016 | 35 | 0.030 |
Why?
|
Muscular Diseases | 1 | 2017 | 161 | 0.030 |
Why?
|
Computer Simulation | 2 | 2011 | 1525 | 0.030 |
Why?
|
Orbital Diseases | 1 | 2017 | 116 | 0.030 |
Why?
|
Pregnancy | 2 | 2020 | 7849 | 0.030 |
Why?
|
Autopsy | 1 | 2016 | 179 | 0.030 |
Why?
|
Genetic Drift | 1 | 2015 | 29 | 0.030 |
Why?
|
Epinephrine | 1 | 2017 | 256 | 0.030 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2016 | 179 | 0.030 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2015 | 8 | 0.030 |
Why?
|
Head and Neck Neoplasms | 1 | 2011 | 4065 | 0.030 |
Why?
|
Epithelium | 1 | 2018 | 728 | 0.030 |
Why?
|
Myelin P0 Protein | 1 | 2015 | 27 | 0.030 |
Why?
|
Myelin P2 Protein | 1 | 2015 | 11 | 0.030 |
Why?
|
Milk, Human | 1 | 2018 | 296 | 0.030 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2015 | 30 | 0.030 |
Why?
|
Megakaryocytes | 1 | 2016 | 123 | 0.030 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2017 | 287 | 0.030 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2015 | 23 | 0.030 |
Why?
|
Data Mining | 1 | 2016 | 87 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 524 | 0.030 |
Why?
|
Texas | 2 | 2017 | 6455 | 0.030 |
Why?
|
Bee Venoms | 1 | 2015 | 9 | 0.030 |
Why?
|
Suppression, Genetic | 1 | 2015 | 67 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 689 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2016 | 411 | 0.030 |
Why?
|
Access to Information | 1 | 2016 | 65 | 0.030 |
Why?
|
Gene Components | 1 | 2015 | 16 | 0.030 |
Why?
|
Cysteine | 1 | 2016 | 214 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2016 | 76 | 0.030 |
Why?
|
Fibrillins | 1 | 2015 | 35 | 0.030 |
Why?
|
Gestational Age | 1 | 2019 | 1104 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2017 | 707 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2011 | 16040 | 0.030 |
Why?
|
Genetic Counseling | 1 | 2017 | 391 | 0.030 |
Why?
|
Lod Score | 1 | 2015 | 129 | 0.030 |
Why?
|
Muscles | 1 | 2016 | 423 | 0.030 |
Why?
|
Glucose-6-Phosphatase | 1 | 2015 | 21 | 0.030 |
Why?
|
Inflammation | 2 | 2018 | 2563 | 0.030 |
Why?
|
Drug Discovery | 1 | 2018 | 334 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2018 | 588 | 0.030 |
Why?
|
Circadian Rhythm Signaling Peptides and Proteins | 1 | 2014 | 9 | 0.030 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 26 | 0.030 |
Why?
|
Penetrance | 1 | 2015 | 127 | 0.030 |
Why?
|
Fibrillin-1 | 1 | 2015 | 59 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2015 | 53 | 0.030 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2015 | 38 | 0.030 |
Why?
|
Diploidy | 1 | 2015 | 112 | 0.030 |
Why?
|
In Vitro Techniques | 1 | 2018 | 1631 | 0.030 |
Why?
|
Sexual Behavior, Animal | 1 | 2015 | 66 | 0.030 |
Why?
|
Scotoma | 1 | 2015 | 21 | 0.030 |
Why?
|
Adaptation, Biological | 1 | 2015 | 49 | 0.030 |
Why?
|
Motor Neurons | 1 | 2015 | 143 | 0.030 |
Why?
|
Transcription Termination, Genetic | 1 | 2014 | 7 | 0.030 |
Why?
|
CREB-Binding Protein | 1 | 2015 | 88 | 0.030 |
Why?
|
Two-Hybrid System Techniques | 1 | 2015 | 182 | 0.030 |
Why?
|
5'-Nucleotidase | 1 | 2015 | 66 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 2018 | 0.030 |
Why?
|
Ampulla of Vater | 1 | 2016 | 157 | 0.030 |
Why?
|
Protein Folding | 1 | 2016 | 292 | 0.030 |
Why?
|
Prostaglandins F | 1 | 2014 | 9 | 0.030 |
Why?
|
Replication Origin | 1 | 2014 | 22 | 0.030 |
Why?
|
Position-Specific Scoring Matrices | 1 | 2014 | 9 | 0.030 |
Why?
|
DNA Polymerase III | 1 | 2014 | 32 | 0.030 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 29 | 0.030 |
Why?
|
Hemoglobins | 1 | 2017 | 481 | 0.030 |
Why?
|
Wool | 1 | 2014 | 3 | 0.030 |
Why?
|
Keratins, Hair-Specific | 1 | 2014 | 4 | 0.030 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2014 | 6 | 0.030 |
Why?
|
Electroretinography | 1 | 2015 | 123 | 0.030 |
Why?
|
Vitamin B 12 | 1 | 2015 | 73 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2022 | 1260 | 0.030 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2014 | 15 | 0.030 |
Why?
|
Hominidae | 1 | 2014 | 37 | 0.030 |
Why?
|
Corneal Opacity | 1 | 2014 | 24 | 0.030 |
Why?
|
Marsupialia | 1 | 2014 | 9 | 0.030 |
Why?
|
Puerto Rico | 1 | 2014 | 66 | 0.030 |
Why?
|
Vitamin B Complex | 1 | 2015 | 52 | 0.030 |
Why?
|
Lysine | 1 | 2016 | 428 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5384 | 0.030 |
Why?
|
Vision Tests | 1 | 2014 | 59 | 0.030 |
Why?
|
Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 67 | 0.030 |
Why?
|
Mice, Inbred CBA | 1 | 2014 | 78 | 0.030 |
Why?
|
Physical Examination | 1 | 2016 | 303 | 0.030 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2014 | 24 | 0.030 |
Why?
|
Fatty Acids, Volatile | 1 | 2014 | 52 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2018 | 1061 | 0.030 |
Why?
|
Oligodendroglioma | 1 | 2014 | 106 | 0.030 |
Why?
|
Gastrulation | 1 | 2014 | 25 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2015 | 303 | 0.030 |
Why?
|
Xanthogranuloma, Juvenile | 1 | 2014 | 38 | 0.030 |
Why?
|
Coloboma | 1 | 2014 | 44 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2018 | 631 | 0.030 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 314 | 0.030 |
Why?
|
Erdheim-Chester Disease | 1 | 2014 | 54 | 0.030 |
Why?
|
Cadherins | 1 | 2017 | 670 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2014 | 104 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 348 | 0.030 |
Why?
|
Neurologic Manifestations | 1 | 2013 | 10 | 0.030 |
Why?
|
Cerebrum | 1 | 2014 | 41 | 0.030 |
Why?
|
Microphthalmos | 1 | 2014 | 54 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2014 | 88 | 0.030 |
Why?
|
Telomere Shortening | 1 | 2014 | 57 | 0.030 |
Why?
|
Population | 1 | 2013 | 25 | 0.030 |
Why?
|
Blindness, Cortical | 1 | 2013 | 17 | 0.030 |
Why?
|
Decision Making | 2 | 2012 | 1341 | 0.030 |
Why?
|
Bile Acids and Salts | 1 | 2016 | 255 | 0.030 |
Why?
|
Visual Fields | 1 | 2015 | 145 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 253 | 0.030 |
Why?
|
Gene Editing | 1 | 2016 | 228 | 0.030 |
Why?
|
Spine | 1 | 2015 | 305 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2014 | 397 | 0.030 |
Why?
|
Proteolysis | 1 | 2015 | 375 | 0.030 |
Why?
|
Animals, Outbred Strains | 1 | 2013 | 14 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 7187 | 0.030 |
Why?
|
Heterografts | 1 | 2016 | 750 | 0.030 |
Why?
|
Clone Cells | 1 | 2015 | 559 | 0.030 |
Why?
|
Population Control | 1 | 2013 | 6 | 0.030 |
Why?
|
Histiocytosis, Sinus | 1 | 2014 | 88 | 0.030 |
Why?
|
RNA | 2 | 2011 | 1026 | 0.030 |
Why?
|
Radiography, Abdominal | 1 | 2014 | 121 | 0.030 |
Why?
|
Pseudogenes | 2 | 2004 | 83 | 0.030 |
Why?
|
Hormones | 1 | 2014 | 276 | 0.030 |
Why?
|
Prevalence | 1 | 2021 | 3391 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2019 | 2054 | 0.030 |
Why?
|
Reference Standards | 1 | 2014 | 359 | 0.030 |
Why?
|
Chromosomes, Human | 1 | 2014 | 279 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 241 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2014 | 244 | 0.030 |
Why?
|
Melopsittacus | 1 | 2012 | 7 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2021 | 972 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 1077 | 0.030 |
Why?
|
Information Dissemination | 1 | 2016 | 274 | 0.030 |
Why?
|
Zinc Fingers | 1 | 2014 | 211 | 0.030 |
Why?
|
Ampicillin Resistance | 1 | 2012 | 10 | 0.030 |
Why?
|
NAV1.4 Voltage-Gated Sodium Channel | 1 | 2012 | 5 | 0.030 |
Why?
|
Population Surveillance | 1 | 2016 | 641 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 7967 | 0.030 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2015 | 204 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2015 | 796 | 0.030 |
Why?
|
Hepatitis B virus | 1 | 2014 | 210 | 0.030 |
Why?
|
CRISPR-Cas Systems | 1 | 2016 | 352 | 0.030 |
Why?
|
Caspase 8 | 1 | 2013 | 148 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2016 | 670 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 1532 | 0.030 |
Why?
|
Incidental Findings | 1 | 2014 | 284 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2016 | 405 | 0.030 |
Why?
|
RNA, Long Noncoding | 1 | 2018 | 611 | 0.030 |
Why?
|
Proline | 1 | 2013 | 128 | 0.030 |
Why?
|
Enzyme Stability | 1 | 2012 | 108 | 0.030 |
Why?
|
Philadelphia Chromosome | 1 | 2017 | 828 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2013 | 103 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2015 | 365 | 0.030 |
Why?
|
Radiation Hybrid Mapping | 1 | 2012 | 10 | 0.030 |
Why?
|
Chromosomes, Insect | 1 | 2012 | 8 | 0.030 |
Why?
|
Solubility | 1 | 2012 | 248 | 0.030 |
Why?
|
Antigens, CD | 1 | 2017 | 1402 | 0.030 |
Why?
|
Hydrolysis | 1 | 2012 | 231 | 0.030 |
Why?
|
Body Weight | 1 | 2017 | 1322 | 0.030 |
Why?
|
Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 436 | 0.030 |
Why?
|
Neutrophils | 1 | 2017 | 846 | 0.030 |
Why?
|
Abdomen | 1 | 2014 | 339 | 0.030 |
Why?
|
Survival Rate | 2 | 2016 | 12465 | 0.030 |
Why?
|
Starvation | 1 | 2012 | 27 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2012 | 91 | 0.030 |
Why?
|
Thermodynamics | 1 | 2012 | 202 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2016 | 628 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 485 | 0.030 |
Why?
|
Calcium Channels, L-Type | 1 | 2012 | 78 | 0.030 |
Why?
|
Mexico | 1 | 2012 | 266 | 0.030 |
Why?
|
Cerebellum | 1 | 2016 | 467 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2017 | 900 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2016 | 7443 | 0.030 |
Why?
|
Research Design | 2 | 2014 | 1583 | 0.030 |
Why?
|
Precision Medicine | 1 | 2020 | 1194 | 0.030 |
Why?
|
Saudi Arabia | 1 | 2011 | 39 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 617 | 0.020 |
Why?
|
Spermatogenesis | 1 | 2014 | 322 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 1112 | 0.020 |
Why?
|
Serine | 1 | 2013 | 389 | 0.020 |
Why?
|
Hepacivirus | 1 | 2014 | 405 | 0.020 |
Why?
|
Electrocardiography | 1 | 2018 | 1250 | 0.020 |
Why?
|
Machine Learning | 1 | 2015 | 354 | 0.020 |
Why?
|
Proteome | 2 | 2008 | 577 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2014 | 295 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 2303 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2019 | 4356 | 0.020 |
Why?
|
F-Box-WD Repeat-Containing Protein 7 | 1 | 2011 | 84 | 0.020 |
Why?
|
Time Factors | 2 | 2018 | 13256 | 0.020 |
Why?
|
Twins, Dizygotic | 1 | 2011 | 48 | 0.020 |
Why?
|
Cerebrosides | 1 | 2011 | 9 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2014 | 419 | 0.020 |
Why?
|
Critical Care | 1 | 2017 | 795 | 0.020 |
Why?
|
Protein Interaction Maps | 1 | 2012 | 150 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2014 | 1315 | 0.020 |
Why?
|
Levodopa | 1 | 2011 | 90 | 0.020 |
Why?
|
Australia | 1 | 2011 | 225 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 1289 | 0.020 |
Why?
|
Myocardium | 1 | 2017 | 1338 | 0.020 |
Why?
|
Photoreceptor Cells | 1 | 2011 | 78 | 0.020 |
Why?
|
Genome, Archaeal | 1 | 2010 | 8 | 0.020 |
Why?
|
Solutions | 1 | 2010 | 107 | 0.020 |
Why?
|
Length of Stay | 1 | 2017 | 2036 | 0.020 |
Why?
|
Insect Viruses | 1 | 2010 | 9 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 34263 | 0.020 |
Why?
|
Protein Kinases | 1 | 2014 | 886 | 0.020 |
Why?
|
Wasp Venoms | 1 | 2010 | 5 | 0.020 |
Why?
|
Risk | 1 | 2014 | 1944 | 0.020 |
Why?
|
Trans-Activators | 1 | 2016 | 1600 | 0.020 |
Why?
|
Urogenital System | 1 | 2010 | 60 | 0.020 |
Why?
|
South Africa | 1 | 2010 | 97 | 0.020 |
Why?
|
Rhabdoid Tumor | 1 | 2011 | 111 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2015 | 1142 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2016 | 1295 | 0.020 |
Why?
|
Wolbachia | 1 | 2010 | 42 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2013 | 695 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 1647 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 774 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 2975 | 0.020 |
Why?
|
Dacarbazine | 1 | 2011 | 489 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2015 | 564 | 0.020 |
Why?
|
Chronic Disease | 1 | 2015 | 1864 | 0.020 |
Why?
|
Respiratory System | 1 | 2010 | 127 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2011 | 589 | 0.020 |
Why?
|
Animals, Domestic | 1 | 2009 | 42 | 0.020 |
Why?
|
Ciliary Body | 1 | 2009 | 36 | 0.020 |
Why?
|
Mouth | 1 | 2010 | 122 | 0.020 |
Why?
|
Locus Control Region | 1 | 2008 | 15 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 1327 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 5127 | 0.020 |
Why?
|
Uveitis | 1 | 2009 | 40 | 0.020 |
Why?
|
Mutant Chimeric Proteins | 1 | 2008 | 24 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 9308 | 0.020 |
Why?
|
Fusidic Acid | 1 | 2008 | 3 | 0.020 |
Why?
|
Deoxyuracil Nucleotides | 1 | 2008 | 11 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2014 | 935 | 0.020 |
Why?
|
Pulmonary Surfactants | 1 | 2008 | 50 | 0.020 |
Why?
|
Operon | 1 | 2008 | 54 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2008 | 132 | 0.020 |
Why?
|
CD11b Antigen | 1 | 2008 | 65 | 0.020 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2008 | 39 | 0.020 |
Why?
|
RNA, Small Untranslated | 1 | 2008 | 31 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2082 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 2008 | 202 | 0.020 |
Why?
|
Growth and Development | 1 | 2008 | 28 | 0.020 |
Why?
|
Taste | 1 | 2008 | 52 | 0.020 |
Why?
|
Vagina | 1 | 2010 | 334 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 9 | 0.020 |
Why?
|
Individuality | 1 | 2008 | 60 | 0.020 |
Why?
|
Genomic Islands | 1 | 2007 | 31 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2014 | 1117 | 0.020 |
Why?
|
Papillomaviridae | 1 | 2011 | 626 | 0.020 |
Why?
|
Oogenesis | 1 | 2008 | 70 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 32 | 0.020 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2009 | 198 | 0.020 |
Why?
|
RNA Stability | 1 | 2008 | 134 | 0.020 |
Why?
|
Spores, Bacterial | 1 | 2007 | 47 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2008 | 283 | 0.020 |
Why?
|
Europe | 1 | 2009 | 652 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 4885 | 0.020 |
Why?
|
Ultrasonography | 1 | 2014 | 1927 | 0.020 |
Why?
|
Methicillin Resistance | 1 | 2007 | 144 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2016 | 3946 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2008 | 168 | 0.020 |
Why?
|
Rifampin | 1 | 2008 | 205 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2012 | 1710 | 0.020 |
Why?
|
Actinobacillus pleuropneumoniae | 1 | 2006 | 2 | 0.020 |
Why?
|
Haemophilus ducreyi | 1 | 2006 | 3 | 0.020 |
Why?
|
Prophages | 1 | 2006 | 6 | 0.020 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 416 | 0.020 |
Why?
|
Hydrolases | 1 | 2007 | 132 | 0.020 |
Why?
|
Adenoviridae | 1 | 2012 | 1456 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2007 | 259 | 0.020 |
Why?
|
Calcification, Physiologic | 1 | 2006 | 53 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2007 | 235 | 0.020 |
Why?
|
Genes, p53 | 1 | 2011 | 1110 | 0.020 |
Why?
|
Nervous System Physiological Phenomena | 1 | 2006 | 21 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2014 | 1657 | 0.020 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2008 | 207 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2011 | 802 | 0.020 |
Why?
|
Karyotyping | 1 | 2008 | 1022 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 539 | 0.020 |
Why?
|
Biofilms | 1 | 2008 | 203 | 0.020 |
Why?
|
Gamma Rays | 1 | 2007 | 241 | 0.020 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2006 | 23 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 5017 | 0.020 |
Why?
|
Complement Activation | 1 | 2006 | 96 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 512 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 3831 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2011 | 1639 | 0.020 |
Why?
|
China | 1 | 2007 | 619 | 0.020 |
Why?
|
Dosage Compensation, Genetic | 1 | 2005 | 64 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2007 | 588 | 0.020 |
Why?
|
Hippocampus | 1 | 2011 | 945 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2008 | 3106 | 0.020 |
Why?
|
Kidney | 1 | 2014 | 2198 | 0.020 |
Why?
|
Frameshifting, Ribosomal | 1 | 2004 | 4 | 0.020 |
Why?
|
Rickettsia conorii | 1 | 2004 | 4 | 0.020 |
Why?
|
Genes, rRNA | 1 | 2004 | 22 | 0.020 |
Why?
|
Rickettsia | 1 | 2004 | 9 | 0.020 |
Why?
|
Electron Transport Complex IV | 1 | 2004 | 57 | 0.020 |
Why?
|
Monocytes | 1 | 2008 | 784 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 5509 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2007 | 512 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2004 | 275 | 0.010 |
Why?
|
DNA, Protozoan | 1 | 2003 | 34 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6262 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2006 | 666 | 0.010 |
Why?
|
Glass | 1 | 2002 | 29 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2005 | 470 | 0.010 |
Why?
|
ErbB Receptors | 1 | 2011 | 2331 | 0.010 |
Why?
|
Smoking | 1 | 2011 | 2402 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2390 | 0.010 |
Why?
|
Microspheres | 1 | 2002 | 213 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 3217 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2007 | 1163 | 0.010 |
Why?
|
Glioblastoma | 1 | 2011 | 1842 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 5237 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 16287 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2016 | 7747 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 6797 | 0.010 |
Why?
|
Models, Biological | 1 | 2008 | 3247 | 0.010 |
Why?
|
Histones | 1 | 2007 | 1490 | 0.010 |
Why?
|
Risk Assessment | 1 | 2011 | 7086 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2005 | 1561 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 5008 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2002 | 4237 | 0.010 |
Why?
|